Literature DB >> 30391469

Impaired Exocrine Pancreatic Function Associates With Changes in Intestinal Microbiota Composition and Diversity.

Fabian Frost1, Tim Kacprowski2, Malte Rühlemann3, Robin Bülow4, Jens-Peter Kühn5, Andre Franke3, Femke-Anouska Heinsen3, Maik Pietzner6, Matthias Nauck7, Uwe Völker8, Henry Völzke9, Ali A Aghdassi1, Matthias Sendler1, Julia Mayerle10, Frank U Weiss1, Georg Homuth8, Markus M Lerch11.   

Abstract

BACKGROUND & AIMS: Changes in intestinal microbiome composition are associated with inflammatory, metabolic, and malignant disorders. We studied how exocrine pancreatic function affects intestinal microbiota.
METHODS: We performed 16S ribosomal RNA gene sequencing analysis of stool samples from 1795 volunteers from the population-based Study of Health in Pomerania who had no history of pancreatic disease. We also measured fecal pancreatic elastase by enzyme-linked immunosorbent assay and performed quantitative imaging of secretin-stimulated pancreatic fluid secretion. Associations of exocrine pancreatic function with microbial diversity or individual genera were calculated by permutational analysis of variance or linear regression, respectively.
RESULTS: Differences in pancreatic elastase levels associated with significantly (P < .0001) greater changes in microbiota diversity than with participant age, body mass index, sex, smoking, alcohol consumption, or dietary factors. Significant changes in the abundance of 30 taxa, such as an increase in Prevotella (q < .0001) and a decrease of Bacteroides (q < .0001), indicated a shift from a type-1 to a type-2 enterotype. Changes in pancreatic fluid secretion alone were also associated with changes in microbial diversity (P = .0002), although to a lesser degree.
CONCLUSIONS: In an analysis of fecal samples from 1795 volunteers, pancreatic acinar cell, rather than duct cell, function is presently the single most significant host factor to be associated with changes in intestinal microbiota composition.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteria; Biomarker; Microbiome; Pancreas

Mesh:

Substances:

Year:  2018        PMID: 30391469     DOI: 10.1053/j.gastro.2018.10.047

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome.

Authors:  Malte Christoph Rühlemann; Britt Marie Hermes; Corinna Bang; Shauni Doms; Lucas Moitinho-Silva; Louise Bruun Thingholm; Fabian Frost; Frauke Degenhardt; Michael Wittig; Jan Kässens; Frank Ulrich Weiss; Annette Peters; Klaus Neuhaus; Uwe Völker; Henry Völzke; Georg Homuth; Stefan Weiss; Harald Grallert; Matthias Laudes; Wolfgang Lieb; Dirk Haller; Markus M Lerch; John F Baines; Andre Franke
Journal:  Nat Genet       Date:  2021-01-18       Impact factor: 38.330

2.  Gut microbial pathways for bile acid metabolism.

Authors:  Fabian Frost; Markus M Lerch
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

3.  Obese Individuals with and without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and Composition.

Authors:  Louise B Thingholm; Malte C Rühlemann; Manja Koch; Brie Fuqua; Guido Laucke; Ruwen Boehm; Corinna Bang; Eric A Franzosa; Matthias Hübenthal; Ali Rahnavard; Fabian Frost; Jason Lloyd-Price; Melanie Schirmer; Aldons J Lusis; Chris D Vulpe; Markus M Lerch; Georg Homuth; Tim Kacprowski; Carsten O Schmidt; Ute Nöthlings; Tom H Karlsen; Wolfgang Lieb; Matthias Laudes; Andre Franke; Curtis Huttenhower
Journal:  Cell Host Microbe       Date:  2019-08-06       Impact factor: 21.023

Review 4.  [The role of the microbiome in diseases of the pancreas].

Authors:  Fabian Frost; Frank U Weiss; Markus M Lerch
Journal:  Internist (Berl)       Date:  2022-02-17       Impact factor: 0.743

Review 5.  [Introduction to the microbiome].

Authors:  Fabian Frost
Journal:  Inn Med (Heidelb)       Date:  2022-09-02

6.  Factors That Affect Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Pancreatitis: A Systematic Review, Meta-Analysis, and Meta-Regression.

Authors:  Bara El Kurdi; Sumbal Babar; Mahmoud El Iskandarani; Adam Bataineh; Markus M Lerch; Mark Young; Vijay P Singh
Journal:  Clin Transl Gastroenterol       Date:  2019-09       Impact factor: 4.488

7.  Changes in fecal microbiota with CFTR modulator therapy: A pilot study.

Authors:  C E Pope; A T Vo; H S Hayden; E J Weiss; S Durfey; S McNamara; A Ratjen; B Grogan; S Carter; L Nay; M R Parsek; P K Singh; E F McKone; M L Aitken; M R Rosenfeld; L R Hoffman
Journal:  J Cyst Fibros       Date:  2020-12-31       Impact factor: 5.527

Review 8.  Gut microbiota in pancreatic diseases: possible new therapeutic strategies.

Authors:  Li-Long Pan; Bin-Bin Li; Xiao-Hua Pan; Jia Sun
Journal:  Acta Pharmacol Sin       Date:  2020-10-22       Impact factor: 7.169

9.  The effect of acupuncture on tumor growth and gut microbiota in mice inoculated with osteosarcoma cells.

Authors:  Xiaoru Xu; Xiangru Feng; Min He; Zepeng Zhang; Jiajia Wang; Haiyu Zhu; Tie Li; Fuchun Wang; Mengmeng Sun; Zhihong Wang
Journal:  Chin Med       Date:  2020-04-07       Impact factor: 5.455

10.  The Gut Microbiome in Patients With Chronic Pancreatitis Is Characterized by Significant Dysbiosis and Overgrowth by Opportunistic Pathogens.

Authors:  Fabian Frost; Frank U Weiss; Matthias Sendler; Tim Kacprowski; Malte Rühlemann; Corinna Bang; Andre Franke; Uwe Völker; Henry Völzke; Georg Lamprecht; Julia Mayerle; Ali A Aghdassi; Georg Homuth; Markus M Lerch
Journal:  Clin Transl Gastroenterol       Date:  2020-09       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.